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ABSTRACT
Diabetic neuropathic pain, an important microvascular complication
in diabetes mellitus, is recognized as
one of the most difficult types of pain
to treat due to underlying neural
pathological changes such as inflammation and fibrosis. It is not possible
to use a single drug as a first-line
treatment for diabetic peripheral neuropathic pain. The aim of this work is
to study the neural pathological
changes and tissue levels of proinflammatory cytokines, TNF-α and IL6 that may underlie the different
types of neuropathic pain (tactile allodynia and thermal hyperalgesia)
and to explore the effects of pioglitazone and/or fluoxetine on these
changes. Sixty adult male white albino rats were assigned into two main
groups, diabetic group with induction
137
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of diabetes by single intra-peritoneal
injection of streptozotocin with high
cholesterol diet and non-diabetic
group fed on normal diet. Each main
group was divided into subgroups
(n=6 rats each) as follows: [I] control,
with no treatment; [II] subjected to
peripheral sciatic nerve ligation
(PSL) only with no treatment; [III]
PSL with pioglitazone treatment; [IV]
PSL with fluoxetine treatment and
[V] PSL with pioglitazone and fluoxetine combined treatment. All subgroups were tested before, at day 7
and day14 after PSL for tactile allodynia and thermal hyperalgesia followed by measurement of nerve tissue levels of TNF-α and IL-6,
quantification of collagen deposition
and macrophages counting. We
found that PSL significantly increased inflammatory cell infiltration
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mainly macrophages and collagen
deposition with significant increase
of nerve tissue levels of TNF-α and
IL-6 in both groups. These changes
were associated with significant increase of tactile allodynia and thermal hyperalgesia. Administration of
pioglitazone and/or fluoxetine significantly decreased both macrophages
infiltration and collagen deposition
and nerve tissue levels of TNF-α and
IL-6. These effects were associated
with significant attenuation of tactile
allodynia and thermal hyperalgesia
produced by PSL in both diabetic
and non-diabetic groups but fluoxetine alone had weaker effect in diabetic group. These results suggested
that macrophages infiltration and collagen deposition with associated elevation of tissue proinflammatory cytokines could be a cause of
neuropathic pain and administration
of pioglitazone and fluoxetine can attenuate neuropathic pain by abolishing these changes.

INTRODUCTION
Neuropathic pain is characterized
by pain in the absence of a stimulus
and by reducing nociceptive thresholds so that normally innocuous stimuli produce pain (Scholz et al.,
2007). Diabetic neuropathic pain, an

important microvascular complication in diabetes mellitus, is recognized as one of the most difficult
types of pain to treat (Chong et al.,
2007). The management of peripheral diabetic neuropathy consists of excluding other causes of painful peripheral neuropathy, maximizing
diabetic control and using medications to alleviate pain (Chong et al.,
2007). It is not possible to nominate
a single drug as the first-line treatment for diabetic peripheral neuropathic pain. Numerous studies using
animal models have proposed candidates for therapeutic targets to reduce neuropathic pain. However currently,
there
are
no
good
pharmacotherapies for neuropathic
pain (Park et al., 2007). Proinflammatory cytokines and the
mRNA of TNF-α and IL-1β increased
in the brain associated with painassociated behavior in the rat models of neuropathic pain (Watkins et
al., 2003). Peroxisome proliferatoractivator receptor (PPAR) is a ligand
activated transcription factor belonging to a nuclear hormone receptor
superfamily, containing three isoforms (α, β/δ, and γ) (Lebovitz et al
2001). PPARγ plays a critical physiological role as a primary lipid sensor and regulator of lipid metabolism.
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Thus, its ligands are clinically used
for treatment of some diseases, including type 2 diabetes (LunaMedina et al 2005). Some studies
evaluated that; pioglitazone attenuates the development and maintenance of allodynia and hyperalgesia
in mice with neuropathic pain due to
peripheral nerve injury (Goldberg et
al., 2005). Antidepressant drugs are
reported to be used as co-analgesics
in clinical management of migraine
and neuropathic pain (Singh et al.,
2001). There is increasing recognition that norepinephrine (NE) and serotonin (5-HT) reuptake inhibitors
(NRIs and SRIs) are efficacious in
treating some types of pain. Studies
have not systematically evaluated
the relative activity at the NE and/or
5-HT transporter required for maximal efficacy in rodent pain models
(Leventhal et al., 2007). Some proinflammatory cytokines contribute to
neuropathic pain TNF-α and IL-6 are
expected mediators underlying tactile allodynia and thermal hyperalgesia induced by peripheral nerve injury (Moalem et al., 2006). Thus, the
aims of the present work were to explore the effects of pioglitazone or/
and fluoxetine on tactile allodynia
and thermal hyperalgesia in neuropathic pain as well as on the patho-

139

logical changes induced experimentally in non-diabetic and diabetic
rats and to clarify their possible neuroimmune mechanism of action.

MATERIALS AND METHODS
1- Drugs and chemicals:
-Streptozotocin
(STZ)
powder
creamy white: (Sigma Chemicals
Co., U.S.A).
-Urethane (Ethyl Carbamate); (Prolabo, Paris) white crystals.
-Fluoxetine powder (Misr Co., Egypt)
-Pioglitazone powder (Unipharma,
Egypt)
-Carboxy-methyle cellulose (powder)
(El Nasr Pharmaceutical Chemicals Co.)
-Ray Bio ® Mouse IL-6: Ray Biotech.U.S.A.
-MEDGENIX TNF-? EASIA Kit.
2-Animals:
Adult male albino rats (n=60),
weighting 150-200 g. They were
brought from (Experimental Animal
Breeding Farm, Helwan - Cairo) .All
animals were housed in controlled
laboratory condition at 20 -25C in a
12h light/dark cycle and had free access to standard laboratory chow
(El-Nasr Company, Abou-Zaabal,
Cairo, Egypt) and water. They have
acclimatized for one week and were
caged (6/cage) in fully ventilated
MANSOURA MEDICAL JOURNAL
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room (at room temperature) in pharmacology department, Benha Faculty of Medicine. All experimental protocols were approved by the
committee of Benha University.
3 – Study Design:
After acclimatization for 1 week,
the rats were assigned into 2 groups’
non-diabetic and diabetic group.
Each group was subdivided into five
experimental groups, 6 rats each
and treated for 14 days as follow:
Group (I): Normal control group. Fed
normal diet, did not receive
any drugs but the sciatic
nerve of right lateral hind
limb in rats was exposed,
and not subjected to ligation.
Group (II): None-treated peripheral
sciatic nerve ligation (PSL)
group.
Fed
40%cholesterol diet. Peripheral
sciatic nerve subjected to
ligation according to the
modified method of Seltzer
Z et al. 2004.
Group (III): Pioglitazone-treated
group. Received pioglitazone (25mg/kg/day) by
gavage according to Maeda et al., 2008.
Group (VI): Fluoxetine-treated
group. Received fluoxetine

(30mg/kg/day) by subcutaneous injection (Jett et al.,
1997).
Group (V): Pioglitazone+fluoxetinetreated group. Received pioglitazone (25mg/kg/day)
by gavage and fluoxetine
(30mg/kg/day) by subcutaneous injection.
Diabetes was induced by a single
intraperitoneal injection of streptozotocin (STZ 60 mg/kg) dissolved in
cold 0.1 mole citrate buffer (pH 4.5)
after fed the rats with high fat diet for
2 weeks as a model for type 2 diabetes (Islam et al., 2007) 72 hours
after STZ injection, diabetes was
confirmed in rats by showing blood
glucose levels increased to > 300
mg/100 ml (Ganda et al., 1976). The
blood glucose concentration was
measured using a glucometer from
blood samples obtained by tail prick.
4- Surgical procedure
The procedure used for induction
of neuropathic pain was the model
adopted by Seltzer Z et al., 2004.
Rats were anaesthetized with urethane (1.5-1.75 g/kg I.P). The left
sciatic nerve was exposed at the
upper-thigh level, and the dorsal
third to half of the sciatic nerve was
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tightly ligated. The wound was then
sutured and the rats were allowed to
recover in their home cage.
5 -Behavioral tests
All the behavioral data were recorded before surgery, at day 7 and
day 14 for all subgroups. The paw
pressure threshold in response to
normal innocuous mechanical stimuli
was measured by using an analgesimeter (Randall et al., 1957). Rats
were situated on the platform under
the situation point, so that this is at
5mm distance. Once the rats are
prepared we activate the start pedal.
The values on the display will increase in a progressive way and
once the selected algesic response
has been reached (shaking of the
stimulated rat, vocalization etc.), we
free the start pedal. The force (g) being exerted at the moment of freeing
the start pedal is considered the
end-point of the test. Once the pedal
is released, the motor will turn counter-wise, at the same time the value
shown at the digital display is transmitted through the RS232 serial connector.
On the other hand, thermal sensitivity was determined by measuring
hind-paw withdrawal latencies to a
radiant heat stimulus according to
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Hargreaves et al., 1988 just before
and after 7 days in non-diabetic
groups, and 14 days after STZ injection with sciatic nerve ligation.
6 -Estimation of serum TNF-α and
IL-6:
After the behavioral testing on
day 7 and day 14 post-surgery, all
rats were deeply anesthetized with
sodium pentobarbital and the sciatic
nerve was dissected (1 cm in length,
including the ligation region). We
determined the change in expression
of tumor necrosis factor-α (TNF-α)
and interleukin-6 (IL-6) in the sciatic
nerve
a- Estimation of TNF-α by a sandwich ELISA with (MEDGENIX
TNF-α EASIA Kit).
TNF-α was determined using a
commercially available kit according
to the manufacture instructions.
b- Estimation of IL-6 by ELISA technique using (Ray Bio ® Mouse IL6):
By following the manufacture instruction according the protocol of
Howord et al., 1992.
7- Histopathological examination:
After the behavioral testing on
day 7 and 14 post-surgery, all rats
were deeply anesthetized and the
sciatic nerve was dissected, fixed
with 10%formaldehyde; embedded in
MANSOURA MEDICAL JOURNAL
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paraffin, cut at 5 um, stained with
hematoxylin and eosin (H&E) and

compared using Student’s t-test or
Mann-Whitney’s U test.

with Masson trichrome and examined. The pathologist was unaware
of the treatment protocol.
a- Quantification of Fibrotic Areas
Quantitative analysis of sciatic
nerve collagen fibers deposition in
masson trichrome-stained tissues
was performed by morphometric
analysis (James et al., 1990). A total
of 10 fields were randomly chosen
per mouse and images were taken
with a digital camera mounted on a
CX41 Olympus optical microscope.
Collagenous areas stained with masson trichrome were extracted and
analyzed using the NIH Image software. The extent of fibrosis was expressed as the percentage of the
stained area relative to the total

RESULTS
1- Behavior test :
Peripheral sciatic nerve ligation
(PSL) induced significantly tactile allodynia ligation which calculated as
the rats showing hind paw withdrawal in response to lower weight
(grams) pressure applied to its hind
paw. Administration of pioglitazone
(25mg/kg, orally) daily and combination of pioglitazone and fluoxetine
once daily alleviated the tactile allodynia in non-diabetic and diabetic
groups. Also, administration of fluoxetine (30mg/kg, s.c) once daily significantly attenuated tactile allodynia
in non-diabetic rats but, could not
successfully improve tactile allodynia
in diabetic rats.

area. The percentages obtained from
the 10 fields were expressed as the
mean ± standard deviation.

STATISTICAL ANALYSIS
Data are shown as mean ±S.E.M.
The results were analyzed by one
way analysis of variant (ANOVA) followed by t-test or turkey test with
p<0.05 selected as the criterion for
statistical significance. The histopathological data were analyzed and

Regarding the thermal hyperalgesia, it was observed that peripheral
sciatic nerve ligation-induced thermal hyperalgesia as sciatic nerve ligation groups had significantly shorter withdrawal latencies, and this was
reversed by pioglitazone administration and combination of pioglitazone
and fluoxetine in non-diabetic and diabetic rats. On the other hand, administration of fluoxetine (30mg/kg,
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s.c) improved thermal hyperalgesia
elicited by peripheral nerve injury in
comparison to the control group in
non-diabetic rats. But administration
of fluoxetine (30mg/kg, s.c) produced no significant improvement in
thermal hyperalgesia in diabetic rats
(table 1).
2- Production of inflammatory cytokines:
TNF-α and IL-6 were at a low level in the control group. Sciatic nerve
ligation was associated with marked
increase in the expression of both
cytokines TNF-α and IL-6 in all examined nerve tissue on day 7 and
14. Pioglitazone and fluoxetine, sup-

143

pressed significantly the elevation of
both cytokines in all examined tissues (table 2).
3- Histopathological examination
Sciatic nerve ligation produced inflammatory cell infiltration with increased collagen fibers deposition in
the injured sciatic nerve in comparison to normal control group. Administration of pioglitazone and /or fluoxetine showed less inflammatory cell
infiltration with significant reduction
of collagen deposition in both groups
non-diabetic group. But fluoxetine
alone show lesser improvement in
diabetic group (P<0.006vs. 0.0009 in
non-diabetic group (Figure 1A, 1B)
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Figure (1):
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Effects of pioglitazone and fluoxetine on histopathological
changes in rats with: A) Non-diabetic peripheral sciatic nerve
neuropathy. B) Diabetic groups.
Sciatic nerve ligation produced inflammatory cell infiltration
with significant increase in the collagen fibers in the injured
sciatic nerve in comparison to normal control group. Administration of pioglitazone and /or fluoxetine decrease the inflammatory cells and significantly reduced the amount of collagen in diabetic and non-diabetic groups but fluoxetine alone showed milder
improvement in diabetic group.
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DISCUSSION
Results of the present work revealed that administration of pioglitazone (25mg/kg/day) attenuated tactile
allodynia
and
thermal
hyperalgesia. These results are in
agreement with Maeda et al., (2008)
who found that pioglitazone attenuated the development and maintenance of allodynia and thermal hyperalgesia in mice with neuropathic
pain due to peripheral nerve injury.
Also, Papans et al., 2011 reported
that pioglitazone has been shown to
improve experimental diabetic neuropathy and alleviate neuropathic
pain. Wiggin et al., 2008 observed
that rosiglitazone reduced oxidative
stress and prevented the develop-

In the present study, fluoxetine
significantly attenuated tactile allodynia and thermal hyperplasia. These
effects are in line with those reported
by Kesim et al., 2006 that fluoxetine
showed significant antinociceptive
effect in non diabetic mice, but they
could not successfully show this effect in diabetic mice. In disagreement with these findings, Sounvoravong et al., 2007 who stated that
fluoxetine itself lacks antinociceptive
properties in diabetic and sciatic
nerve ligation mice, as model of neuropathic pain. Jett et al., 1997 added
that fluoxetine (3-30mg/kg, s.c) did
not inhibit either hyperalgesia or allodynia in formalin model and the L5/
L6 spinal nerve ligation model of
neuropathic pain.

ment of thermal hypoalgesia in streptozotocin-induced diabetic mice. In
addition, Churi et al., 2008 found that
PPARδ ligand-induced activation of
spinal PPAR-gamma rapidly reverses nerve injury-induced mechanical
allodynia. On contrast to these finding, Shibata et al., 2000 reported
that troglitazone was less effective in
controlling neuropathy in the Zucker
diabetic fatty (ZDF) rats. This difference in our results may be due to
uses of different doses and different
species of animals.

Some proinflammatory cytokines
contribute to neuropathic pain. TNFα and IL-6 are accepted mediators
underlying tactile allodynia and thermal hyperalgesia induced by peripheral nerve injury (Moalem et al.,
2006). Sciatic nerve injury increases
the levels of both cytokines in the
sciatic nerve, dorsal root ganglion,
and spinal cord (Murphy et al., 1995,
Deleo et al., 1996, George et al.,
1999, and Ignatowski et al., 1999
which agrees with the present study.
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Transcription of both cytokines is
regulated by transcription factor
binding sites within the promoter. It
has been reported that promoter activities of both TNF-α and IL-6 are
driven by binding of NF-κB, AP-1,
and STAT, primary proinflammatory
transcription factors (Chinetti et al.,
2000). We therefore, tested whether
pioglitazone and fluoxetine blocked
partial sciatic nerve ligation induced
up-regulation of both cytokines. Administration of pioglitazone and fluoxetine after PSL reduced increases
in the expression level of both cytokines in all examined tissues. These
results strongly suggest that pioglitazone and fluoxetine alleviates tactile
allodynia and thermal hyperalgesia,
at least in part, through inhibiting the
upregulated proinflammatory cytokines. These results are in congruent
with those of Maeda et al., 2008 who
reported that pioglitazone alleviates
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partial sciatic nerve ligation. Administration of pioglitzone and fluoxetine
decreased
the
histopathological
changes in the sciatic nerve sections
of the treated diabetic and non diabetic rats. These results are in line
with Takahashi et al., 2011 who reported that, rosiglitazone treatment
in the early phase of neuropathic
pain significantly alleviated the development of tactile allodynia by regulating macrophage infiltration and
production of proinflammatory molecules at the inflamd site.
In conclusion, pioglitazone in
combination with fluoxetine may be
an effective combination in attenuating diabetic and non-diabetic neuropathic pain through inhibiting the
over expression of pro-inflammatory
cytokines with subsequent decrease
in inflammatory cell infiltration and
nerve fibrosis.

neuropathic pain through attenuation
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ا ﻠﺨﺺ اﻟﻌﺮﺑﻰ
ﺗﺄﺛﻴﺮ ﺗﺂزر اﻟﻔﻮﻟﻮﻛﺴﺘ ﻣﻊ ﺑﻴﻮﺟﻠﻴﺘﺎزوﻧﻰ ﻋﻠﻰ اﻟﺴﻴﻄﺮة
ﻋﻠﻰ اﻟﺴﻜﺮ واﻟﻠﻤﺲ وﻓﺮط اﻻﻟﻢ اﳊﺮارى ﻓﻰ اﻟﻔﺌﺮان اﻟﻐﻴﺮ
ﻣﺼﺎﺑﺔ ﺑﺎﻟﺴﻜﺮى وا ﺼﺎﺑﺔ ﺑﺎﻟﺴﻜﺮى وا ﻌﺮﺿﺔ ﻟﻺﺻﺎﺑﺔ

ﺑﺎﻟﺘﻬﺎب اﻟﻌﺼﺐ اﻟﻄﺮﻓﻰ.
أﻣﺎﻧﻰ ﻧﺼﺮ ﻋﺒﺪ اﻟﻬﺎدى إﺑﺮاﻫﻴﻢ و ﻋﻤﺮو ﻋﻮض اﻟﻜﺎرف
ﻗﺴﻤــﻰ اﻟﻔـ ــﺎرﻣ ــﺎﻛـ ــﻮﻟـ ــﻮﭼ ــﻰ  -ﻛﻠﻴ ـ ــﺔ ﻃـ ــﺐ ﺑﻨﻬ ـ ـ ـ ـ ــﺎ
ﺟﺎﻣﻌﺔ ﺑﻨﻬﺎ وﻗﺴﻢ اﻟﺒﺎﺛﻮﻟﻮﭼﻰ  -ﻛﻠﻴّﺔ ﻃﺐ ا ﻨﺼﻮرة
آﻻم اﻷﻋـﺼﺎب اﻟـﻄﺮﻓـﻴﺔ ﻫـﻮ ﻣﺸـﻜﻠﺔ ﻫـﺎﻣﺔ وﺧـﺎﺻﺔ ﺑـ ﻣﺮﺿﻰ اﻟـﺴﻜـﺮى .واﻟﻌﻼﻗﺔ اﻟـﺪﻗﻴـﻘﺔ ﺑـ اﻟﺴـﻴﻄﺮة
ﻋﻠﻰ ﺳﻜﺮ اﻟﺪم وﲢﺴ ﺷﺪة إﻋﺘﻼل اﻷﻋﺼﺎب اﶈﻴﻄﻴﺔ ﻣﻊ اﻟﺴﻜﺮى ﻻﺗﺰال ﻣﺜﻴﺮة ﻟﻠﺠﺪل .
اﻟ ـﻬـﺪف  :ﻣـﻦ ﻫـﺬه اﻟـﺪراﺳــﺔ ﻫـﻮ إﺳ ـﺘـﻜـﺸــﺎف آﺛـﺎر ﺑـﻴــﻮﺟـﻠ ـﻴـﺘـﺎزوﻧـﻰ )٢٥ﻣـﺠﻢ/ﻛـﺠـﻢ ﺑـﺎﻟـﻔـﻢ( وﻓـﻠـﻮﻛ ـﺴـﺘـ
)٣٠ﻣـﺠﻢ/ﻛﺠﻢ ﲢﺖ اﳉﻠﺪ( واﳉﻤﻊ ﺑ اﻟـﺪواءﻳﻦ إﻣﺎ ﻓﻰ ﺟﺮﻋﺔ ﻣﻨﺨﻔـﻀﺔ )١٠ﻣﺠﻢ/ﻛﺠﻢ( أو إرﺗﻔﺎع ﺟﺮﻋﺔ
ﺑـﻴﻮﺟـﻠﻴﺘـﺎزوﻧﻰ إﻟﻰ )٢٥ﻣﺠﻢ/ﻛـﺠﻢ( وﻓﻠـﻮﻛﺴﺘـ )٣٠ﻣﺠﻢ/ﻛـﺠﻢ ﲢﺖ اﳉﻠﺪ( ﺗـﻌﻄﻰ ﻣـﺮة واﺣﺪة ﻳﻮﻣـﻴﺎً ﺪة ٧
أﻳـﺎم و  ١٤ﻳﻮﻣﺎً ﻋﻠﻰ اﻟﻠﻤﺲ وﻓﺮط اﻟﺘـﺄﻟﻢ اﳊﺮارﻳﺔ ﻓﻰ ﻮذج أﻟﻢ اﻷﻋﺼﺎب اﻟﺴﻜـﺮى وﻏﻴﺮ اﻟﺴﻜﺮى ﻓﻰ اﻟﻔﺌﺮان
وآﻟـﻴﺔ اﻟـﻌﻤﻞ ا ﻤـﻜﻨـﺔ ورﺻﺪ آﺛﺎرﻫـﺎ ﻋﻠﻰ ﻣﺴـﺘﻮﻳـﺎت اﻟﺴﻜـﺮ ﻓﻰ اﻟﺪم .وﻗﻴـﺎس ﻋﺎﻣﻞ ﺗـﺂﻛﻞ اﻷورام أﻟﻔﺎ ﻓﻰ أﻧـﺴﺠﺔ
اﻷﻋﺼﺎب ﻓﻰ اﻟﻔﺌﺮان ا ﺼﺎﺑﺔ ﺑﺎﻟﺴﻜﺮى وﻏﻴﺮ اﻟﺴﻜﺮى .
ﺗﻘﺴﻴﻢ اﻟﻔﺌﺮان إﻟﻰ ﻣﺠﻤﻮﻋﺘ :
اﺣﺪاﻫﻤﺎ ﻏﻴﺮ ﻣﺼﺎﺑﺔ ﺑﺎﻟﺴﻜﺮى واﻷﺧﺮى ﻣﺼﺎﺑﺔ ﺑﺎﻟﺴﻜﺮى ﻋﻦ ﻃﺮﻳﻖ اﳊﻘﻦ داﺧﻞ اﻟﺼﻔﺎق ﺑﺠﺮﻋﺔ واﺣﺪة
ﻣـﻦ اﻟﺴـﺘـﺮﺑـﺘـﻮزوﺗـﻮﺳـ ) ٦٠ﻣـﺠﻢ/ﻛـﺠﻢ( ﺑـﻌﺪ ﺗـﻐـﺬﻳـﺔ اﻟـﻔـﺌـﺮان ﻣﻊ ﺣـﻤـﻴﺔ ﻋـﺎﻟـﻴـﺔ اﻟـﺪﻫـﻮن ) %٤٠ﻣﻦ اﻟـﺴـﻌﺮات
اﳊـﺮارﻳﺔ واﻟـﺪﻫﻮن( ﺪة أﺳـﺒﻮﻋ ﺑـﺎﻋﺘﺒـﺎره ﻮذج ﺮض اﻟـﺴﻜـﺮى ﻣﻦ اﻟﻨﻮع اﻟـﺜﺎﻧﻰ .وأﻛﺪ اﻟـﺴﻜﺮى ﻓﻰ اﻟـﻔﺌﺮان
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ﻣـﻦ ﺧﻼل أﻇﻬـﺎر زﻳﺎدة ﻣـﺴﺘـﻮﻳﺎت اﻟـﺴـﻜﺮ ﻓﻰ اﻟـﺪم ﺑﻌـﺪ  ١٨ﺳﺎﻋـﺔ و  ٧٢ﺳﺎﻋـﺔ ﺻـﻴﺎم ﺑـﻌﺪ اﳊـﻘﻦ .وﻗﺪ

ﻗـﻴﺎس

ﺗﺮﻛﻴﺰ اﻟﺴﻜﺮ ﻓﻰ اﻟﺪم ﺑﺎﺳﺘﺨﺪام ﻋﻴﻨﺎت دم ﻣﻦ وﺧﺰ اﻟﺬﻳﻞ وﻗﻴﺎﺳﻬﺎ ﺑﺎﻟﻜﻠﻮﻣﺘﺮ .
ﺛﻢ

ﺗﻘﺴﻴﻢ اﻟﻔﺌﺮان اﻟﻐﻴﺮ ﻣﺼﺎﺑﺔ وا ﺼﺎﺑﺔ ﺑﺎﻟﺴﻜﺮى إﻟﻰ ﺧﻤﺴﺔ ﻣﺠﻤﻮﻋﺎت :

اﺠﻤﻟﻤﻮﻋﺔ اﻷوﻟﻰ :
ﻣﺠﻤﻮﻋﺔ ا ﺮاﻗﺒﺔ وﺗﺸﻤﻞ  ٦ﻓﺌﺮان .
اﺠﻤﻟﻤﻮﻋﺔ اﻟﺜﺎﻧﻴﺔ :
اﺠﻤﻟﻤﻮﻋﺔ ا ﺼﺎﺑﺔ ﺑﺎﻟﺘﻬﺎب اﻻﻋﺼﺎب اﻟﻄﺮﻓﻰ ﺑﺪون أى ﻋﻼج وﺗﺸﻤﻞ  ٦ﻓﺌﺮان .
اﺠﻤﻟﻤﻮﻋﺔ اﻟﺜﺎﻟﺜﺔ :
ﻣﺠﻤﻮﻋﺔ اﻟﺒﺎﻳﻮﺟﻠﻴﺘﺎزون )٢٥ﻣﺠﻢ/ﻛﺠﻢ( وﺗﺸﻤﻞ  ٦ﻓﺌﺮان .
اﺠﻤﻟﻤﻮﻋﺔ اﻟﺮاﺑﻌ ــﺔ :
ﻣﺠﻤﻮﻋﺔ اﻟﻔﻠﻮﻛﺴﻴﺘ ) ٣٠ﻣﺠﻢ /ﻛﺠﻢ( وﺗﺸﻤﻞ  ٦ﻓﺌﺮان
اﺠﻤﻟﻤﻮﻋﺔ اﳋﺎﻣﺴﺔ :
ﻣﺠﻤﻮﻋﺔ اﻟﺒﺎﻳﻮﺟﻠﻴﺘﺎزون ) ٢٥ﻣﺠﻢ /ﻛﺠﻢ( واﻟﻔﻠﻮﻛﺴﻴﺘ ) ٣٠ﻣﺠﻢ /ﻛﺠﻢ( وﺗﺸﻤﻞ  ٦ﻓﺌﺮان .
اﻟـﻔﺌـﺮان ﺼـﺎﺑﺔ وﻏـﻴﺮ ا ـﺼﺎﺑـﺔ ﺑﺎﻟـﺴﻜـﺮى ﺧﻀـﻌﺖ ﻟﺮﺑﻂ اﻟـﻌﺼﺐ اﻟـﻮرﻛﻰ .ﺛﻢ

ﻗﻴـﺎس اﻟﻠـﻤﺲ ﺑﺎﺳـﺘﺨﺪام

ﺟـﻬﺎز ﻗﻴﺎس اﻷﻟﻢ ﻗـﺒﻞ وﺑﻌﺪ اﳉﺮاﺣﺔ .و ﺗـﻘﻴﻴﻢ ﻓﺮط اﻟـﺘﺄﻟﻢ اﳊﺮارﻳﺔ اﻟﺴـﺎﺧﻨﺔ ﺑﺎﺳـﺘﺨﺪام ﻟﻮﺣﺔ ﻓﻰ ﻛﻞ ﻣﻦ
اﻟـﻔﺌﺮان ا ـﺼﺎﺑﺔ ﺑﺎﻟـﺴﻜﺮى وﻏﻴـﺮ ﻣﺼﺎﺑﺔ ﺑـﺎﻟﺴﻜﺮى .و ﻗـﻴﺎس ﻣﺴـﺘﻮى اﻟﺴﻜـﺮ ﻓﻰ اﻟﺪم ﻟﻜﻞ اﺠﻤﻟﻤـﻮﻋﺎت ﻛﻤﺎ
ﻗـﻴـﺎس وزن اﻟـﻔـﺌﺮان ﻗـﺒﻞ وﺑـﻌـﺪ اﳉـﺮاﺣﺔ .ﺛﻢ ﺗـﻤﺖ اﻟـﺘـﻀـﺤﻴـﺔ ﺑـﺎﻟـﻔـﺌﺮان ﺑـﻌـﺪ  ١٤ﻳـﻮم ﻣﻦ اﻟـﻌﻤـﻠـﻴـﺔ و ﻓﺤﺺ
ﻣـﺠﻬـﺮى ﻟﺘـﺤﺪﻳﺪ اﻟـﺘﻐـﻴﺮات اﻟﺒـﺎﺛﻮﻟـﻮﭼﻴﺔ ا ـﺼﺎﺣـﺒﺔ ﻓﻰ أﻧـﺴﺠﺔ اﻻﻋـﺼﺎب وﺗـﻌﻴ ﻣـﺴﺘـﻮى ﻋﺎﻣﻞ ﺗﺂﻛﻞ اﻷورام
أﻟﻔﺎ ﻓﻰ أﻧﺴﺠﺔ اﻷﻋﺼﺎب ا ﺼﺎﺑﺔ واﻟﻐﻴﺮ ﻣﺼﺎﺑﺔ ﺑﺎﻟﺴﻜﺮى
وﻗﺪ ﺗﺒ اﻵﺗﻰ ﻣﻦ اﻟﻨﺘﺎﺋﺞ :
 -١اﻹﻟ ـﺘ ـﻬــﺎب اﻷﻋ ـﺼــﺎب اﻟـﻄــﺮﻓﻰ أدى إﻟـﻰ ﻓـﺮط اﻷﻟـﻢ اﻟـﻨــﺎﰋ ﻋﻦ اﻟ ـﻠــﻤﺲ وﻓــﺮط اﻟ ـﺘــﺄﻟﻢ اﳊــﺮارى ـﺪة
أﺳـﺒﻮﻋ  .أﻣﺎ اﻋﻄﺎء ﺑﻴﻮﺟﻠﻴﺘﺎزون وﺣﺪه وﻓﻠﻮﻛﺴﺘ وﺣﺪه وﻛﻼ اﻟﺪواﺋ ﻣﻌﺎ ﺪة  ٧أﻳﺎم ﻟﻠﻔﺌﺮان اﻟﻐﻴﺮ
ﻣـﺼﺎﺑﺔ ﺑﺎﻟﺴﻜﺮى أدى إﻟﻰ وﻫﻦ اﻟـﺘﺄﻟﻢ اﻟﻨﺎﰋ ﻋﻦ اﻟﻠﻤﺲ ووﻫﻦ اﻟﺘﺄﻟﻢ اﳊـﺮارى وﻟﻜﻦ ﻓﻠﻮﻛﺴﺘ وﺣﺪه
ﻻ ﻳﻈﻬﺮ ﺑﻨﺠﺎح ﻫﺬه اﻵﺛﺎر ﻓﻰ اﻟﻔﺌﺮان ا ﺼﺎﺑﺔ ﺑﺎﻟﺴﻜﺮى ﺑﻌﺪ  ١٤ﻳﻮﻣﺎ ﻣﻦ رﺑﻂ اﻟﻌﺼﺐ اﻟﻄﺮﻓﻰ .
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-٢وأﻣـﺎ اﻋﻄﺎء ﺑﻴﻮﺟﻠﻴﺘﺎزون وﺣﺪه وﻓﻠﻮﻛﺴﺘ وﺣﺪه ﻛﺎن ﻟﻪ آﺛﺎر ﺿﺌﻴﻠﺔ ﻋﻠﻰ ﺳﻜﺮ اﻟﺪم ﻓﻰ اﻟﻔﺌﺮان ا ﺼﺎﺑﺔ
ﺑــﺎﻟـﺴـﻜـﺮى وﻏ ـﻴـﺮ ا ـﺼـﺎﺑـﺔ ﺑــﺎﻟـﺴـﻜـﺮى وﻟــﻜﻦ ﻣـﺰﻳﺞ ﻣﻦ ﺑـﻴــﻮﺟـﻠـﻴـﺘــﺎزوﻧﻰ )٢٥ﻣـﺠﻢ/ﻛـﺠﻢ( وﻓ ـﻠـﻮﻛـﺴـﺘـ
)٣٠ﻣﺠﻢ/ﻛﺠﻢ( ﻛﺎن ﻟﻬﺎ آﺛﺎر ﻛﺒﻴﺮة ﻓﻰ ﺳﻜﺮ اﻟﺪم ﻓﻰ اﻟﻔﺌﺮان ا ﺼﺎﺑﺔ ﺑﺎﻟﺴﻜﺮى .
 -٣أن زﻋـﻄﺎء اﻟـﺒﻴـﻮﺟﻠﻴـﺘﺎزون أدﻟﻰ إﻟﻰ زﻳـﺎدة وزن اﻟﻔﺌـﺮان أﻣﺎ اﻋـﻄﺎء اﻟﻔـﻠﻮﻛـﺴﺘ ﻓـﺄدى إﻟﻰ ﻓﻘـﺪان ﻟﻠﻮزن
ﻓﻰ ﻛﻼ ﻣﻦ اﻟﻔﺌﺮان ا ﺼﺎﺑﺔ ﺑﺎﻟﺴﻜﺮى وﻏﻴﺮ ﻣﺼﺎﺑﺔ ﺑﺎﻟﺴﻜﺮى .
 -٤ﻣـﺴ ـﺘـﻮى ﻋـﺎﻣﻞ ﺗـﺂﻛﻞ اﻷورام أﻟـﻔـﺎ ﻛـﺎن ﻣـﺮﺗـﻔـﻌـﺎً ﻓﻰ أﻧـﺴـﺠـﺔ أﻋـﺼـﺎب اﻟـﻔـﺌـﺮان ا ـﺼـﺎﺑـﺔ واﻟـﻐـﻴـﺮ ﻣـﺼـﺎﺑـﺔ
ﺑـﺎﻟﺴﻜﺮى وا ﺼﺎﺑﺔ ﺑـﺎﻟﺘﻬﺎب اﻷﻋﺼﺎب اﻟﻄـﺮﻓﻰ ﺑﺎ ﻘﺎرﻧﺔ ﺑﺎﺠﻤﻟﻤـﻮﻋﺔ اﻟﻀﺎﺑﻄﺔ .أﻣﺎ اﻋـﻄﺎء ﺑﻴﻮﺟﻠﻴﺘﺎزون
وﺣــﺪه وﻓـﻠـﻮﻛـﺴـﺘـ وﺣـﺪه وﻛﻼ اﻟـﺪاوﺋـ ﻣـﻌـﺎ ـﺪة  ٧أﻳـﺎم ﻟ ـﻠـﻔـﺌـﺮان اﻟـﻐـﻴـﺮ ﻣـﺼـﺎﺑـﺔ ﺑـﺎﻟـﺴـﻜـﺮى أدى إﻟﻰ
إﻧﺨﻔﺎض ﻣﺴﺘﻮى ﻋﺎﻣﻞ ﺗﺂﻛﻞ اﻷورام أﻟﻔﺎ .
 -٥اﻟـﺘﻐﻴﺮات اﻟﺒﺎﺛﻮﻟﻮﭼﻴـﺔ ا ﺼﺎﺣﺒﺔ ﻓﻰ أﻧﺴﺠﺔ اﻷﻋﺼﺎب ﻛـﺎﻧﺖ ﻓﻰ ﺻﻮرة زﻳﺎدة ﻓﻰ اﳋﻼﻳﺎ ا ﻠﺘﻬﻤﺔ وزﻳﺎدة
ﻓـﻰ ﺗﺮﺳﺐ اﻷﻧﺴﺠﺔ اﻟﻠﻴﻔﻴﺔ ﻓﻰ اﻷﻋـﺼﺎب واﻟﺘﻰ ﲢﺴﻨﺖ ﻛﺜﻴﺮاً ﻋﻨﺪ ا ـﻌﺎﳉﺔ ﺰﻳﺞ ﻣﻦ ﺑﻴﻮﺟﻠﻴﺘﺎزوﻧﻰ
)٢٥ﻣﺠﻢ/ﻛﺠﻢ( وﻓﻠﻮﻛﺴﺘ )٣٠ﻣﺠﻢ/ﻛﺠﻢ( ﺑﺎ ﻘﺎرﻧﺔ ﺑﺎﻋﻄﺎء ﻛﻼ ﻣﻨﻬﻤﺎ ﻋﻠﻰ ﺣﺪة .
اﳋﻼﺻـ ـ ــﺔ :
ﻫـﺬا ﻳﺸـﻴﺮ إﻟﻰ أن ﺑﻴـﻮﺟﻠـﻴﺘﺎزوﻧﻰ وﻓـﻠﻮﻛـﺴﺘ ﻳـﺨﻔﻒ آﻻم اﻷﻋـﺼﺎب ﻓﻰ اﻟﻔـﺌﺮان ﻋـﻠﻰ ﺣﺪ ﺳﻮاء وذﻟﻚ ﻣﻦ
ا ـﻤﻜﻦ ﻋﻦ ﻃﺮﻳﻖ ﺗﻮﻫ ﺧـﻠﻮى وإﻧﺨﻔﺎض ﻣﺴـﺘﻮى ﻋﺎﻣﻞ ﺗﺂﻛﻞ اﻷورام أﻟﻔﺎ واﻟـﺘﻰ أدت إﻟﻰ ﲢﺴﻦ ﻓﻰ اﻟﺘﻐﻴﺮات
ا ـﺼﺎﺣﺒﺔ ﻓﻰ اﻷﻧـﺴﺠﺔ وﻛﺎن ﻫـﻨﺎك إرﺗﺒﺎط ﺑـ ﻣﺴﺘﻮﻳـﺎت اﻟﺴﻜﺮ ﻓﻰ اﻟـﺪم واﻟﺘﺴﻜـ ﻋﻠﻰ اﻟﺮﻏﻢ ﻣﻦ أن اﳉﻤﻊ
ﺑـ ﺟﺮﻋﺎت ﻋـﺎﻟﻴﺔ ﻣﻦ ﻛـﻼ ﻣﻦ اﻟﺪواﺋ ﻳـﺴﺒﺐ إﻧﺨـﻔﺎض ﻣﻠـﺤﻮظ ﻓﻰ ﻣﺴـﺘﻮى اﻟﺴـﻜﺮ ﻓﻰ اﻟﺪم .ﻛـﻤﺎ أن اﺿﺎﻓﺔ
اﻟﻔﻠﻮﻛﺴﺘ إﻟﻰ ﺑﻴﻮﺟﻠﻴﺘﺎزون ﻣﻨﻊ زﻳﺎدة اﻟﻮزن اﻟﺘﻰ ﻳﺴﺒﺒﻬﺎ اﻟﺒﻴﻮﺟﻠﻴﺘﺎزون ﻓﻰ اﻟﻔﺌﺮان .

Vol. 42, No. 1 & 2 Jan. & April, 2013

18

https://mmj.mans.edu.eg/home/vol42/iss2/1
DOI: 10.21608/mjmu.2020.124890

